series-a
Stage
1
Investors
About
Neurogene develops gene therapies for rare neurological disorders, focusing on genetic medicines to treat conditions such as Rett syndrome.
Explore Neurogene's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.